# Antisecretory Factor In Severe Traumatic Brain Injury

> **NCT04117672** · PHASE2 · RECRUITING · sponsor: **Peter Siesjö** · enrollment: 20 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DIETARY_SUPPLEMENT:** Salovum
- **DIETARY_SUPPLEMENT:** Placebo egg yolk powder

## Key facts

- **NCT ID:** NCT04117672
- **Lead sponsor:** Peter Siesjö
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-10
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04117672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04117672, "Antisecretory Factor In Severe Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04117672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*